Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Disease × Mitomycin × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 34 Non-Muscle Invasive Bladder Neoplasms 22 Carcinoma, Transitional Cell 14 Neoplasms 3 Carcinoma 3 Recurrence 2 Carcinoma in Situ 2 Virus Diseases 1 Urothelial Carcinoma of the Bladder 1 Urothelial Carcinoma Ureter 1 Urologic Neoplasms 1 Urogenital Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Disease 1 Adenoviridae Infections 1

Interventions

Blood Specimen Collection 3 Surveys and Questionnaires 2 Prednisone 2 Positron-Emission Tomography 2 Magnetic Resonance Imaging 2 Injections 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 vistusertib 1 pembrolizumab 1 ioflupane 1 gossypol acetic acid 1 carbon-11 acetate 1 abiraterone 1 Urine Specimen Collection 1 Urination 1 Therapeutics 1 Specimen Handling 1 Referral and Consultation 1 Prostatectomy 1 Preoperative Exercise 1 Positron Emission Tomography Computed Tomography 1 Pluvicto 1 Music Therapy 1 Multiparametric Magnetic Resonance Imaging 1 Mitomycin 1 Liquid Biopsy 1 Interviews as Topic 1 Interleukin-15 1 Food 1 Fluorodeoxyglucose F18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03335059 2020-04-15

RITE-USA

Medical Enterprises Ltd.

Phase 3 Terminated

Urinary Bladder Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡